INR 750.9
(-0.05%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 2.09 Billion INR | 0.0% |
2022 | 1.58 Billion INR | 9.26% |
2021 | 1.45 Billion INR | 21.4% |
2020 | 1.19 Billion INR | 2.34% |
2019 | 1.16 Billion INR | 12.75% |
2018 | 1.03 Billion INR | 5.12% |
2017 | 985 Million INR | -9.89% |
2016 | 1.09 Billion INR | 19.57% |
2015 | 914.23 Million INR | 10.97% |
2014 | 823.83 Million INR | 25.43% |
2013 | 656.8 Million INR | 12.18% |
2012 | 585.5 Million INR | -0.91% |
2011 | 590.88 Million INR | 27.87% |
2010 | 462.1 Million INR | 12.88% |
2009 | 409.39 Million INR | 14.88% |
2008 | 356.35 Million INR | -0.29% |
2007 | 357.38 Million INR | 16.26% |
2006 | 307.38 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 223.2 Million INR | -40.56% |
2023 Q4 | 375.51 Million INR | -7.11% |
2023 Q1 | 314.85 Million INR | -16.15% |
2023 FY | 1.58 Billion INR | 0.0% |
2023 Q2 | 431.1 Million INR | 36.92% |
2023 Q3 | 404.24 Million INR | -6.23% |
2022 FY | 1.58 Billion INR | 9.26% |
2022 Q1 | 337.03 Million INR | -8.14% |
2022 Q2 | 423.57 Million INR | 25.68% |
2022 Q3 | 448.64 Million INR | 5.92% |
2022 Q4 | 375.51 Million INR | -16.3% |
2021 Q2 | 384.32 Million INR | 24.88% |
2021 FY | 1.45 Billion INR | 21.4% |
2021 Q3 | 391.44 Million INR | 1.85% |
2021 Q4 | 366.88 Million INR | -6.28% |
2021 Q1 | 307.76 Million INR | -23.1% |
2020 FY | 1.19 Billion INR | 2.34% |
2020 Q1 | 186.27 Million INR | -31.98% |
2020 Q3 | 343.36 Million INR | 29.59% |
2020 Q2 | 264.95 Million INR | 42.24% |
2020 Q4 | 400.19 Million INR | 16.55% |
2019 Q3 | 362.33 Million INR | 18.62% |
2019 Q4 | 273.84 Million INR | -24.42% |
2019 Q1 | 225.88 Million INR | -15.02% |
2019 Q2 | 305.45 Million INR | 35.23% |
2019 FY | 1.16 Billion INR | 12.75% |
2018 Q2 | 247.87 Million INR | 17.3% |
2018 FY | 1.03 Billion INR | 5.12% |
2018 Q4 | 265.8 Million INR | -14.39% |
2018 Q3 | 310.49 Million INR | 25.26% |
2018 Q1 | 211.3 Million INR | -31.52% |
2017 FY | 985 Million INR | -9.89% |
2017 Q1 | 191.25 Million INR | -39.85% |
2017 Q2 | 193.19 Million INR | 1.01% |
2017 Q3 | 306.49 Million INR | 58.65% |
2017 Q4 | 308.58 Million INR | 0.68% |
2016 Q2 | 251.19 Million INR | 0.0% |
2016 FY | 1.09 Billion INR | 19.57% |
2016 Q4 | 317.96 Million INR | 18.89% |
2016 Q3 | 267.45 Million INR | 6.47% |
2015 FY | 914.23 Million INR | 10.97% |
2014 FY | 823.83 Million INR | 25.43% |
2013 FY | 656.8 Million INR | 12.18% |
2012 Q4 | 234.83 Million INR | 38.61% |
2012 FY | 585.5 Million INR | -0.91% |
2012 Q2 | 107.8 Million INR | 46.78% |
2012 Q3 | 169.42 Million INR | 57.16% |
2012 Q1 | 73.44 Million INR | 0.0% |
2011 FY | 590.88 Million INR | 27.87% |
2010 FY | 462.1 Million INR | 12.88% |
2009 FY | 409.39 Million INR | 14.88% |
2008 FY | 356.35 Million INR | -0.29% |
2007 FY | 357.38 Million INR | 16.26% |
2006 FY | 307.38 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Sigachi Industries Limited | 579.88 Million INR | -261.111% |
Ind-Swift Limited | 946.56 Million INR | -121.224% |
Bajaj HealthCare Limited | 985.34 Million INR | -112.518% |
Sakar Healthcare Limited | 204.07 Million INR | -926.091% |
Aurobindo Pharma Limited | 55.65 Billion INR | 96.238% |
Innova Captab Limited | 931.03 Million INR | -124.916% |
Divi's Laboratories Limited | 14.17 Billion INR | 85.222% |
AstraZeneca Pharma India Limited | 2.47 Billion INR | 15.341% |
Morepen Laboratories Limited | 1.98 Billion INR | -5.363% |
Mankind Pharma Limited | 29.27 Billion INR | 92.846% |
Sequent Scientific Limited | 2.9 Billion INR | 27.837% |
Wanbury Limited | 978.96 Million INR | -113.903% |
Laurus Labs Limited | 11.9 Billion INR | 82.418% |
Nectar Lifesciences Limited | 932.7 Million INR | -124.513% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 82.011% |
Alembic Limited | 872.45 Million INR | -140.016% |
Hikal Limited | 4.46 Billion INR | 53.088% |
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 86.805% |
Neuland Laboratories Limited | 2.92 Billion INR | 28.525% |
J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 85.844% |
Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 95.54% |
IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | 4.86% |
Themis Medicare Limited | 1.12 Billion INR | -86.005% |
RPG Life Sciences Limited | 1.63 Billion INR | -28.037% |
Zydus Lifesciences Limited | 125.21 Billion INR | 98.328% |
Lupin Limited | 125.09 Billion INR | 98.326% |
Wockhardt Limited | 8.48 Billion INR | 75.306% |
Vaishali Pharma Limited | 84.02 Million INR | -2392.041% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 31.888% |
Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -377.491% |
Jubilant Pharmova Limited | 14.45 Billion INR | 85.512% |
FDC Limited | 3.49 Billion INR | 40.166% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 97.816% |
Kilitch Drugs (India) Limited | 412.42 Million INR | -407.735% |
Eris Lifesciences Limited | 4.94 Billion INR | 57.636% |
Venus Remedies Limited | 1.91 Billion INR | -9.276% |
ZIM Laboratories Limited | 1.01 Billion INR | -106.705% |
Bliss GVS Pharma Limited | 1.41 Billion INR | -47.548% |
Par Drugs and Chemicals Limited | 58.28 Million INR | -3492.568% |
Caplin Point Laboratories Limited | 2.17 Billion INR | 3.7% |
Shilpa Medicare Limited | 3.33 Billion INR | 37.195% |
Albert David Limited | 1.02 Billion INR | -104.068% |
Ajanta Pharma Limited | 30.46 Billion INR | 93.126% |
Hester Biosciences Limited | 908.84 Million INR | -130.408% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | -49.277% |
Solara Active Pharma Sciences Limited | 2.55 Billion INR | 18.013% |
Gufic Biosciences Limited | 1.18 Billion INR | -76.475% |
Windlas Biotech Limited | 1 Billion INR | -108.049% |
Procter & Gamble Health Limited | 2.99 Billion INR | 30.092% |
Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -14633.251% |
Mangalam Drugs & Organics Limited | 162.22 Million INR | -1190.799% |
Granules India Limited | 10.31 Billion INR | 79.695% |
Aarti Drugs Limited | 1.16 Billion INR | -79.364% |
Bal Pharma Limited | 555.62 Million INR | -276.879% |
Alkem Laboratories Limited | 32.83 Billion INR | 93.623% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 98.642% |
Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -94.942% |
Medicamen Biotech Limited | 335.16 Million INR | -524.774% |
Unichem Laboratories Limited | 6.72 Billion INR | 68.866% |
Bafna Pharmaceuticals Limited | 455.58 Million INR | -359.637% |
Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -30604.355% |
Valiant Laboratories Limited | 138.02 Million INR | -1417.099% |
Orchid Pharma Limited | 800.77 Million INR | -161.503% |
Medico Remedies Limited | 59.67 Million INR | -3409.069% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 1.419% |
Ipca Laboratories Limited | 18.98 Billion INR | 88.972% |
Brooks Laboratories Limited | 51.18 Million INR | -3991.514% |
Syncom Formulations (India) Limited | 345.63 Million INR | -505.856% |
Piramal Enterprises Limited | 63.65 Billion INR | 96.71% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 90.225% |
NATCO Pharma Limited | 10.05 Billion INR | 79.18% |
Suven Life Sciences Limited | 109.75 Million INR | -1808.006% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -4436.868% |
Strides Pharma Science Limited | 9.16 Billion INR | 77.145% |
Indoco Remedies Limited | 12.06 Billion INR | 82.638% |
Alpa Laboratories Limited | 127.38 Million INR | -1543.929% |
Lasa Supergenerics Limited | 291.17 Million INR | -619.17% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 31.941% |